In Brief: Ad Hoc Committee on the Safety of Ma Huang
This article was originally published in The Tan Sheet
Executive Summary
Ad Hoc Committee on the Safety of Ma Huang: D.C.-based group plans to fund clinical studies on ephedra at Vanderbilt and Harvard Universities, committee spokesperson Bill Appler says. The committee hopes to finalize funding arrangements for the studies during a meeting at the Natural Products Expo East Oct. 18-21 in Baltimore, Md. The group also will take a new name and establish itself as a permanent organization during that meeting...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning